Cargando…
New dual dye for vitreoretinal surgery with increased transparency
OBJECTIVES: To develop a new dye formulation for vitreoretinal surgery, which shows increased transparency for better intraoperative handling with better parameters important for use. METHODS AND ANALYSIS: A new blue dye, DDG, was synthesised and tested for toxicity and staining. Diglycerol as new d...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9490597/ https://www.ncbi.nlm.nih.gov/pubmed/36161825 http://dx.doi.org/10.1136/bmjophth-2022-001116 |
_version_ | 1784793119703695360 |
---|---|
author | Mohr, Andreas Cendoya, Paula Wilinska, Joanna Apostu, Maria Apostu, Elena Janku, Jori Wilfling, Tom Ramos, Gabriela Al-Joumhawy, Mahmoud Gabel, Detlef |
author_facet | Mohr, Andreas Cendoya, Paula Wilinska, Joanna Apostu, Maria Apostu, Elena Janku, Jori Wilfling, Tom Ramos, Gabriela Al-Joumhawy, Mahmoud Gabel, Detlef |
author_sort | Mohr, Andreas |
collection | PubMed |
description | OBJECTIVES: To develop a new dye formulation for vitreoretinal surgery, which shows increased transparency for better intraoperative handling with better parameters important for use. METHODS AND ANALYSIS: A new blue dye, DDG, was synthesised and tested for toxicity and staining. Diglycerol as new density-increasing additive was identified, and its toxicity and lack of influence of the staining with trypan blue (TB) on a collagen membrane as model for the epiretinal membrane was determined. Transparency of the dye solution was evaluated. RESULTS: DDG is as alternative to Brilliant Blue G (BBG), with good staining properties for interna limitans models, and a good safety profile. Diglycerol is a new non-toxic additive replacing PEG3350, with reduced viscosity and no reduction in staining, allowing the reduction of TB to achieve the same staining level of the collagen membrane by 40%, with greater transparency of the dye solution and reduced viscosity. Both factors should facilitate a safe removal during surgery. CONCLUSION: A new dye preparation with improved performance in comparison to marketed combinations of BBG and TB was developed. Its reduced TB concentration and viscosity with maintained density allow better tolerance and handling. |
format | Online Article Text |
id | pubmed-9490597 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-94905972022-09-22 New dual dye for vitreoretinal surgery with increased transparency Mohr, Andreas Cendoya, Paula Wilinska, Joanna Apostu, Maria Apostu, Elena Janku, Jori Wilfling, Tom Ramos, Gabriela Al-Joumhawy, Mahmoud Gabel, Detlef BMJ Open Ophthalmol Original Research OBJECTIVES: To develop a new dye formulation for vitreoretinal surgery, which shows increased transparency for better intraoperative handling with better parameters important for use. METHODS AND ANALYSIS: A new blue dye, DDG, was synthesised and tested for toxicity and staining. Diglycerol as new density-increasing additive was identified, and its toxicity and lack of influence of the staining with trypan blue (TB) on a collagen membrane as model for the epiretinal membrane was determined. Transparency of the dye solution was evaluated. RESULTS: DDG is as alternative to Brilliant Blue G (BBG), with good staining properties for interna limitans models, and a good safety profile. Diglycerol is a new non-toxic additive replacing PEG3350, with reduced viscosity and no reduction in staining, allowing the reduction of TB to achieve the same staining level of the collagen membrane by 40%, with greater transparency of the dye solution and reduced viscosity. Both factors should facilitate a safe removal during surgery. CONCLUSION: A new dye preparation with improved performance in comparison to marketed combinations of BBG and TB was developed. Its reduced TB concentration and viscosity with maintained density allow better tolerance and handling. BMJ Publishing Group 2022-09-20 /pmc/articles/PMC9490597/ /pubmed/36161825 http://dx.doi.org/10.1136/bmjophth-2022-001116 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Original Research Mohr, Andreas Cendoya, Paula Wilinska, Joanna Apostu, Maria Apostu, Elena Janku, Jori Wilfling, Tom Ramos, Gabriela Al-Joumhawy, Mahmoud Gabel, Detlef New dual dye for vitreoretinal surgery with increased transparency |
title | New dual dye for vitreoretinal surgery with increased transparency |
title_full | New dual dye for vitreoretinal surgery with increased transparency |
title_fullStr | New dual dye for vitreoretinal surgery with increased transparency |
title_full_unstemmed | New dual dye for vitreoretinal surgery with increased transparency |
title_short | New dual dye for vitreoretinal surgery with increased transparency |
title_sort | new dual dye for vitreoretinal surgery with increased transparency |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9490597/ https://www.ncbi.nlm.nih.gov/pubmed/36161825 http://dx.doi.org/10.1136/bmjophth-2022-001116 |
work_keys_str_mv | AT mohrandreas newdualdyeforvitreoretinalsurgerywithincreasedtransparency AT cendoyapaula newdualdyeforvitreoretinalsurgerywithincreasedtransparency AT wilinskajoanna newdualdyeforvitreoretinalsurgerywithincreasedtransparency AT apostumaria newdualdyeforvitreoretinalsurgerywithincreasedtransparency AT apostuelena newdualdyeforvitreoretinalsurgerywithincreasedtransparency AT jankujori newdualdyeforvitreoretinalsurgerywithincreasedtransparency AT wilflingtom newdualdyeforvitreoretinalsurgerywithincreasedtransparency AT ramosgabriela newdualdyeforvitreoretinalsurgerywithincreasedtransparency AT aljoumhawymahmoud newdualdyeforvitreoretinalsurgerywithincreasedtransparency AT gabeldetlef newdualdyeforvitreoretinalsurgerywithincreasedtransparency |